0 items USD 0.00Search
Your search for "current partnering option evaluation partnering terms agreements pharma biotech" gave back 83406 results.
This report describes and analyzes the situation of antibody-drug conjugates as of November 2015 regarding: ADC pipeline, ADC technologies, ADC...
Catalog:
La Merie Publishing
November 2015
Price: USD 2,500.00
Co-development partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Co-development partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities The field of oncolytic viruses...
Catalog:
La Merie Publishing
January 2017
Price: USD 2,400.00
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of...
Catalog:
La Merie Publishing
January 2018
Price: USD 2,800.00
The global Hepatocyte Growth Factor market size was valued at USD 46 million in 2023 and is forecast to a readjusted size of USD 271 million by 2030...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Hepatocyte Growth Factor market size was valued at US$ 44 million in 2023. With growing demand in downstream market, the Hepatocyte Growth...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Type 2 Diabetes (T2D) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of T2D. The global Type 2...
Catalog:
IQ4I
July 2015
Price: USD 3,600.00
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Smart Pills in Fertility Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
September 2023
Price: USD 4,480.00
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
The global Smart Pills in Fertility Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by...
Catalog:
GIR
September 2023
Price: USD 3,480.00
The report TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of technologies opens business opportunities beyond CD19 CARTs...
Catalog:
La Merie Publishing
June 2016
Price: USD 2,750.00
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
